Cargando…

Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer

Human epidermal growth factor receptor 2 oncogene (HER2-positive) overexpression/amplification occurs in less than 20% of breast cancers and has traditionally been associated with poor prognosis. Development of therapies that target HER2 has significantly improved outcomes for patients with HER2-pos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aapro, Matti, Cardoso, Fatima, Curigliano, Giuseppe, Eniu, Alexandru, Gligorov, Joseph, Harbeck, Nadia, Mueller, Andreas, Pagani, Olivia, Paluch-Shimon, Shani, Senkus, Elzbieta, Thürlimann, Beat, Zaman, Khalil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597182/ https://www.ncbi.nlm.nih.gov/pubmed/36279803 http://dx.doi.org/10.1016/j.breast.2022.07.011

Ejemplares similares

Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic
por: Curigliano, Giuseppe, et al.
Publicado: (2020)

In Honor of Hans-Jörg Senn
por: Thürlimann, Beat, et al.
Publicado: (2023)

International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?
por: Pagani, Olivia, et al.
Publicado: (2010)

Changing the landscape of European School of Oncology–European Society for Medical Oncology masterclasses in clinical oncology during the COVID-19 pandemic
por: Pavlidis, Nicholas, et al.
Publicado: (2022)

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
por: Cardoso, F., et al.
Publicado: (2020)

Customizing early breast cancer therapies – The 2021 St. Gallen International Breast Cancer Consensus Conference()
por: Gnant, Michael, et al.
Publicado: (2022)

International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy
por: Cardoso, Fatima, et al.
Publicado: (2009)

Palliative care: needs of advanced breast cancer patients
por: Cherny, Nathan I, et al.
Publicado: (2018)

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies
por: Paluch-Shimon, Shani, et al.
Publicado: (2020)

Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99
por: Eppenberger-Castori, Serenella, et al.
Publicado: (2020)

Eight-Year Experience of the Certificate of Competence and Advanced Studies Program Organized by the European School of Oncology
por: Pavlidis, Nicholas, et al.
Publicado: (2021)

Correction to: Eight-Year Experience of the Certifcate of Competence and Advanced Studies Program Organized by the European School of Oncology
por: Pavlidis, Nicholas, et al.
Publicado: (2021)

Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data
por: Schmid, Sabine, et al.
Publicado: (2019)

New horizon in breast cancer therapy: highlights from the European Society for Medical Oncology
por: Senkus, Elżbieta
Publicado: (2017)

PROCURE European consensus on breast cancer multigene signatures in early breast cancer management
por: Curigliano, Giuseppe, et al.
Publicado: (2023)

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
por: Cardoso, F, et al.
Publicado: (2017)

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
por: Cardoso, F., et al.
Publicado: (2017)

Is radiotherapy after primary chemotherapy (RAPCHEM) on the right path to de-escalation?
por: Socha, Joanna, et al.
Publicado: (2023)

The PROMISe to increase precision in adjuvant therapy for early breast cancer: To “Type” or to “Print”?
por: Cardoso, Fatima, et al.
Publicado: (2018)

Palonosetron as an anti-emetic and anti-nausea agent in oncology
por: Aapro, Matti S
Publicado: (2007)

SIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderly
por: Aapro, Matti
Publicado: (2011)

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—concluding thoughts
por: Aapro, Matti
Publicado: (2018)

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—introduction
por: Aapro, Matti
Publicado: (2018)

CINV: still troubling patients after all these years
por: Aapro, Matti
Publicado: (2018)

The Role of Multigene Assays in Addressing Treatment Heterogeneity for Breast Cancer
por: Aapro, Matti
Publicado: (2017)

Why is appropriate healthcare inaccessible for many European breast cancer patients? – The EBCC 12 manifesto
por: Cardoso, Fatima, et al.
Publicado: (2021)

Obstetric complications at time of delivery amongst breast cancer survivors: A population-based cohort study
por: Kaidar-Person, Orit, et al.
Publicado: (2022)

Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16–20 March 2004
por: Senkus-Konefka, Elżbieta, et al.
Publicado: (2004)

Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
por: Stanowicka-Grada, Malwina, et al.
Publicado: (2023)

Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D
por: Graffeo, R., et al.
Publicado: (2022)

Lost but Not Least—Novel Insights into Progesterone Receptor Loss in Estrogen Receptor-Positive Breast Cancer
por: Kunc, Michał, et al.
Publicado: (2021)

Are All Societies Ready for Digital Tools? Feasibility Study on the Use of Mobile Application in Polish Early Breast Cancer Patients Treated with Perioperative Chemotherapy
por: Suchodolska, Grażyna, et al.
Publicado: (2023)

Phase I trial of the androgen receptor modulator CR1447 in breast cancer patients
por: Zweifel, Martin, et al.
Publicado: (2017)

Screening is associated with lower mastectomy rates in eastern Switzerland beyond stage effects
por: Herrmann, Christian, et al.
Publicado: (2021)

Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases
por: Aapro, Matti, et al.
Publicado: (2010)

Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?
por: Aapro, Matti, et al.
Publicado: (2010)

From guidelines to clinical practice: a roadmap for oncologists for nutrition therapy for cancer patients
por: Muscaritoli, Maurizio, et al.
Publicado: (2019)

Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
por: Eniu, Alexandru, et al.
Publicado: (2016)

40 years of progress in female cancer death risk: a Bayesian spatio-temporal mapping analysis in Switzerland
por: Herrmann, Christian, et al.
Publicado: (2015)

Unmet needs in asthma
por: Gruffydd-Jones, Kevin
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j5gul706aa7n4a2hvn9pe8b4ar